← All trials
NCT07176689
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 17, 2025
- Primary completion
- Feb 28, 2031
- Completion date
- Mar 30, 2031
- First posted
- Sep 16, 2025
- Last posted
- Nov 19, 2025
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- SpringWorks Therapeutics, Inc.Lead sponsor
- Netherlands Cancer InstituteOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.